FDA Expands Approval of Drug to Stave Off Type 1 Diabetes
(MedPage Today) -- The FDA expanded the approval for teplizumab (Tzield), a biologic that delays the progression of preclinical type ...
(MedPage Today) -- The FDA expanded the approval for teplizumab (Tzield), a biologic that delays the progression of preclinical type ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.